Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Absorbable Polymers International (API) is a specialized manufacturer of bioabsorbable polymers used in the medical device and pharmaceutical industries. The company focuses on the synthesis of high-purity polymers such as polylactide (PLA), polyglycolide (PGA), and polycaprolactone (PCL) for applications in sutures, orthopedic implants, and controlled-release drug delivery systems. API provides custom polymer synthesis and contract manufacturing services to support the development of biodegradable medical products. Originally a division of Pelham Research, the company was acquired by Poly-Med in 2006 to expand its portfolio of absorbable materials. Its expertise lies in tailoring polymer properties like degradation rates and mechanical strength to meet specific clinical requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Absorbable Polymers International.